DexCom
(NASDAQ) DXCM
DexCom Financials at a Glance
Market Cap
$26.49B
Revenue (TTM)
$4.82B
Net Income (TTM)
$930.40M
EPS (TTM)
$2.34
P/E Ratio
29.36
Dividend
$0.00
Beta (Volatility)
1.10 (Average)
Dividend
$0.00
Beta (Volatility)
1.10 (Average)
Price
$68.64
Volume
150,024
Open
$69.75
Price
$68.64
Volume
150,024
Open
$69.75
Previous Close
$68.64
Daily Range
$68.59 - $70.76
52-Week Range
$54.11 - $89.98
Estimated Earnings Date
Jul 29, 2026
Dividend
$0.00
Beta (Volatility)
1.10 (Average)
Price
$68.64
Volume
150,024
Open
$69.75
Previous Close
$68.64
Daily Range
$68.59 - $70.76
52-Week Range
$54.11 - $89.98
Estimated Earnings Date
Jul 29, 2026
DXCM News
DXCM: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout DexCom
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
11,100
CEO
Jacob S. Leach
Website
www.dexcom.comHeadquarters
San Diego, CA 92121, US
DXCM Financials
Key Financial Metrics (TTM)
Gross Margin
61.84%
Operating Margin
21.45%
Net Income Margin
19.31%
Return on Equity
33.83%
Return on Capital
22.05%
Return on Assets
14.03%
Earnings Yield
3.41%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$26.49B
Shares Outstanding
385.87M
Volume
150.02K
Avg. Volume
5.52M
Financials (TTM)
Gross Profit
$2.98B
Operating Income
$1.03B
EBITDA
$1.48B
Operating Cash Flow
$1.78B
Capital Expenditure
-$353.10M
Free Cash Flow
$1.43B
Cash & ST Invst.
$2.42B
Total Debt
$1.38B
DexCom Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.19B
+15.0%
Gross Profit
$750.30M
+27.4%
Gross Margin
62.95%
N/A
Market Cap
$26.49B
N/A
Market Cap/Employee
$2.60M
N/A
Employees
10,200
N/A
Net Income
$199.50M
+89.3%
EBITDA
$336.60M
+53.7%
Quarterly Fundamentals
Total Cash
$2.42B
-10.6%
Total Debt
$1.38B
-46.4%
Accounts Receivable
$1.11B
-5.5%
Inventory
$693.60M
+28.9%
Long Term Debt
$1.36B
+0.7%
Short Term Debt
$20.50M
-98.3%
Return on Assets
14.03%
N/A
Return on Invested Capital
23.44%
N/A
Free Cash Flow
$449.00M
+363.8%
Operating Cash Flow
$525.60M
+186.0%